N-Acetylgalactosamine-4-Sulfatase

Download PDF

Recent Publications on N-Acetylgalactosamine-4-Sulfatase:
Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates. The sulfatase enzymes, N-acetylgalactosamine-4-sulfatase (arylsulfatase B...	29th May, 2008	Department of Medicine, University of Illinois, Chicago, IL 60612, USA.	J Biol Chem. 2008 Apr 11;283(15):9523-30. Epub 2008 Feb 18. DOI Direct Link
Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase. The objective of this study was to evaluate the long-term clinical...	27th May, 2008	Children's Hospital & Research Center Oakland, 747 52nd Street, Oakland,	Mol Genet Metab. 2008 Aug;94(4):469-75. Epub 2008 May 23. DOI Direct Link
Genetic analysis of mucopolysaccharidosis type VI in Taiwanese patients. BACKGROUND: Mucopolysaccharidosis type VI (MPS VI; Maroteaux-Lamy...	20th May, 2008	Department of Medical Research, China Medical University Hospital,	Clin Chim Acta. 2008 Aug;394(1-2):89-93. Epub 2008 Apr 27. DOI Direct Link
Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle. Mucopolysaccharidosis VI (MPS VI) is caused by deficient activity of...	14th May, 2008	Telethon Institute of Genetics and Medicine, Naples, Italy.	Mol Ther. 2008 Jan;16(1):30-7. Epub 2007 Oct 23. DOI Direct Link
Structural and clinical implications of amino acid substitutions in N-acetylgalactosamine-4-sulfatase: insight into mucopolysaccharidosis type VI. To elucidate the basis of mucopolysaccharidosis type VI (MPS VI) from the...	22nd April, 2008	Graduate School of Agricultural and Life Sciences, The University of	Mol Genet Metab. 2008 Apr;93(4):419-25. Epub 2008 Jan 8. DOI Direct Link
→View more research publications.

BioNews Results for N-Acetylgalactosamine-4-Sulfatase:
Merck to fund settlement with former Vioxx painkiller users in August	The Peak 95.1 FM:  Jul 19 2008 1:28AM Matching: n 4
Merck to fund settlement with former Vioxx painkiller users in August	Canoe Money:  Jul 18 2008 7:06PM Matching: n 4
Vioxx settlement to move ahead	Times & Transcripts:  Jul 18 2008 3:50PM Matching: n 4
Vioxx settlement to move ahead	Times & Transcripts:  Jul 18 2008 2:24PM Matching: n 4
Vioxx cheques to start in August	Daily Gleaner:  Jul 18 2008 11:13AM Matching: n 4
Promote your company here: BioNewsCast - Press Release Distribution	→View more news.

N-Acetylgalactosamine-4-Sulfatase Clinical Trials:
Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI	Mucopolysaccharidosis VI

N-Acetylgalactosamine-4-Sulfatase Patents:
US Patent No.	Title
7396824	2-O sulfatase nucleic acid compositions
6534302	22438, 23553, 25278, and 26212 novel human sulfatases
6582692	Recombinant adeno-associated virus virions for the treatment of lysosomal disorders
6677137	Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activity
6767727	22438, 23553, 25278, and 26212 novel human sulfatases
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for N-Acetylgalactosamine-4-Sulfatase scientists - we have details of around 10 individuals working on N-Acetylgalactosamine-4-Sulfatase .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.